Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stockholm - Delayed Quote SEK

Hamlet BioPharma AB ser. B (HAMLET-B.ST)

Compare
4.3500
+0.0500
+(1.16%)
At close: February 28 at 5:29:42 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
49,195.4400
42,534.0740
20,538.7200
17,121.0610
7,502.3620
Operating Income
-49,195.4400
-42,534.0740
-20,538.7200
-17,121.0610
-7,502.3620
Net Non Operating Interest Income Expense
709.6210
717.4130
97.3650
-75.6820
-219.1420
Pretax Income
-48,485.8180
-41,816.6610
-20,441.3540
-17,196.7430
-7,721.5040
Net Income Common Stockholders
-48,485.8180
-41,816.6610
-20,441.3540
-17,196.7430
-7,721.5040
Diluted NI Available to Com Stockholders
-48,485.8180
-41,816.6610
-20,441.3540
-17,196.7430
-7,721.5040
Basic EPS
-0.25
-0.25
-0.18
-1.50
-0.07
Diluted EPS
-0.25
-0.25
-0.18
-1.50
-0.07
Basic Average Shares
193,575.6850
167,736.3060
112,068.8270
114,873.9910
104,901.8920
Diluted Average Shares
193,575.6850
167,736.3060
112,068.8270
114,873.9910
104,901.8920
Total Operating Income as Reported
-49,195.4390
-42,534.0740
-20,538.7190
-17,121.0610
-7,502.3620
Total Expenses
49,195.4400
42,534.0740
20,538.7200
17,121.0610
7,502.3620
Net Income from Continuing & Discontinued Operation
-48,485.8180
-41,816.6610
-20,441.3540
-17,196.7430
-7,721.5040
Normalized Income
-48,485.8180
-41,816.6610
-20,441.3540
-17,196.7430
-7,721.5040
Interest Expense
--
--
--
75.6820
219.1420
Net Interest Income
709.6210
717.4130
97.3650
-75.6820
-219.1420
EBIT
-49,195.4400
-42,534.0740
-20,538.7200
-17,121.0610
-7,502.3620
EBITDA
-38,667.0610
-32,929.9260
-20,039.9700
-17,112.0610
-7,466.3620
Reconciled Depreciation
10,528.3790
9,604.1480
498.7500
9
36
Net Income from Continuing Operation Net Minority Interest
-48,485.8180
-41,816.6610
-20,441.3540
-17,196.7430
-7,721.5040
Normalized EBITDA
-38,667.0610
-32,929.9260
-20,039.9700
-17,112.0610
-7,466.3620
6/30/2021 - 10/23/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

O33.F Glycorex Transplantation AB (publ)
0.2030
-5.58%
 
DMYD-B.ST Diamyd Medical AB (publ)
10.00
-36.71%
 
ATORX.ST Alligator Bioscience AB (publ)
0.0683
-36.76%
 
FARON.HE Faron Pharmaceuticals Oy
2.0100
-0.99%
 
PRLD Prelude Therapeutics Incorporated
0.7590
+1.88%
 
TRVI Trevi Therapeutics, Inc.
4.5200
+0.44%
 
RPTX Repare Therapeutics Inc.
1.1800
-1.67%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
4.9100
+30.93%
 
ALDX Aldeyra Therapeutics, Inc.
5.11
-19.40%
 
OSRH OSR Holdings, Inc.
3.0400
-8.43%